\-\ Texto\\:\\ \ \(0\)\
\-\ c\\ reactive\\ protein\\:\\ 5\\.4\\ \\(0\\.071\\ \\-\\ 5\\.00\\)\\ mg\\/dl\ \(0\)\
\-\ cortisol\\ 2\\.4\\ micrograms\\/dl\ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ noncontrast\\ axial\\ images\\ of\\ the\\ brain\\ demonstrate\\ significant\\ vasogenic\\ edema\\ with\\ effacement\\ of\\ the\\ sulci\\ in\\ the\\ right\\ parietal\\ and\\ posterior\\ frontal\\ white\\ matter\\.\\ \\ concern\\ was\\ for\\ underlying\\ neoplasm\\.\ \(0\)\
\-\ mri\\ images\\ demonstrate\\ motion\\ artifact\\ on\\ several\\ sequences\\.\\ \\ an\\ irregular\\ 2x1\\.5\\ cm\\ contrast\\ enhancing\\ lesion\\ in\\ the\\ right\\ parietal\\ lobe\\ adjacent\\ to\\ the\\ posterior\\ falx\\ with\\ a\\ broad\\ base\\ which\\ extends\\ into\\ the\\ medial\\ right\\ parietal\\ lobe\\ with\\ indistinct\\ margins\\.\\ \\ extensive\\ vasogenic\\ edema\\ is\\ present\\ in\\ the\\ surrounding\\ white\\ matter\\ with\\ sulcal\\ effacement\\ and\\ mass\\ effect\\ on\\ the\\ posterior\\ horn\\ of\\ the\\ right\\ lateral\\ ventricle\\.\ \(0\)\
\-\ mr\\ spectroscopy\\ performed\\ in\\ a\\ single\\ voxel\\ was\\ limited\\ by\\ motion\\ but\\ demonstrates\\ a\\ significant\\ decrease\\ in\\ naa\\ and\\ slight\\ choline\\ peak\\ elevation\\.\\ \\ no\\ lactate\\ peak\\ was\\ present\\.\ \(0\)\
\-\ neoplastic\\ disease\ \(4\)\
\-\ \\â\\€\\¢\\ infection\ \(8\)\
\-\ \\â\\€\\¢\\ metastatic\\ lesion\ \(0\)\
\-\ \\â\\€\\¢\\ lymphoma\ \(6\)\
\-\ \\â\\€\\¢\\ meningioma\ \(7\)\
\-\ \\â\\€\\¢\\ primary\\ neoplasm\\ \\(glioblastoma\\ multiforme\\)\ \(0\)\
\-\ 75\\ year\\ old\\ man\\ with\\ new\\ onset\\ of\\ left\\ lower\\ extremity\\ weakness\\ and\\ recent\\ back\\ surgery\\.\\ \\ patient\\ has\\ no\\ known\\ primary\\ neoplastic\\ disease\\.\ \(0\)\
\-\ patient\\ is\\ pending\\ definite\\ diagnosis\\ however\\ it\\ is\\ suspected\\ that\\ he\\ has\\ a\\ primary\\ lung\\ neoplasm\\.\\ \\ noncontrast\\ ct\\ is\\ important\\ in\\ initial\\ evaluation\\ of\\ neurological\\ deficits\\.\\ \\ however\\,\\ mri\\ was\\ necessary\\ to\\ characterize\\ the\\ underlying\\ lesion\\.\\ \\ the\\ study\\ was\\ limited\\ secondary\\ to\\ artifact\\ which\\ limited\\ definite\\ evaluation\\ of\\ whether\\ this\\ was\\ intraaxial\\ or\\ extraaxial\\ however\\ it\\ shared\\ characteristics\\ of\\ both\\ lesions\\.\\ \\ mr\\ spectroscopy\\ aided\\ in\\ narrowing\\ a\\ broad\\ differential\\ by\\ the\\ decrease\\ in\\ naa\\ and\\ elevation\\ of\\ cho\\ to\\ suggest\\ neoplastic\\ disease\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ naa\\:\\ 0\\.051268313538236805\ \(0\)\
\-\ neoplastic\\:\\ 0\\.04787810767309688\ \(0\)\
\-\ spectroscopy\\:\\ 0\\.04753965935016388\ \(0\)\
\-\ parietal\\:\\ 0\\.03997152317565311\ \(0\)\
\-\ limited\\:\\ 0\\.03948210515830377\ \(0\)\
\-\ peak\\:\\ 0\\.03550565478383263\ \(0\)\
\-\ effacement\\:\\ 0\\.034221781305995666\ \(0\)\
\-\ vasogenic\\:\\ 0\\.033765428335328994\ \(0\)\
\-\ definite\\:\\ 0\\.033765428335328994\ \(0\)\
\-\ noncontrast\\:\\ 0\\.03333593563443167\ \(0\)\
\-\ artifact\\:\\ 0\\.03313030879525871\ \(0\)\
\-\ broad\\:\\ 0\\.03236125393644245\ \(0\)\
\-\ 5\\.00\\:\\ 0\\.032173424904987216\ \(0\)\
\-\ micrograms\\/dl\\:\\ 0\\.032173424904987216\ \(0\)\
\-\ 2x1\\.5\\:\\ 0\\.032173424904987216\ \(0\)\
\-\ voxel\\:\\ 0\\.032173424904987216\ \(0\)\
\-\ neoplasm\\:\\ 0\\.03186302820341527\ \(0\)\
\-\ elevation\\:\\ 0\\.030805829006072323\ \(0\)\
\-\ 0\\.071\\:\\ 0\\.02964369066936698\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.028595152401384813\ \(0\)\
\-\ decrease\\:\\ 0\\.02854192441991291\ \(0\)\
\-\ shared\\:\\ 0\\.028163891004738643\ \(0\)\
\-\ aided\\:\\ 0\\.028163891004738643\ \(0\)\
\-\ cho\\:\\ 0\\.028163891004738643\ \(0\)\
\-\ primary\\:\\ 0\\.027715886090098868\ \(0\)\
\-\ underlying\\:\\ 0\\.026731582696851962\ \(0\)\
\-\ however\\:\\ 0\\.026051475061281793\ \(0\)\
\-\ motion\\:\\ 0\\.02507752606150393\ \(0\)\
\-\ choline\\:\\ 0\\.02507156304712111\ \(0\)\
\-\ 5\\.4\\:\\ 0\\.024584222198126504\ \(0\)\
\-\ matter\\:\\ 0\\.02455824795912991\ \(0\)\
\-\ cortisol\\:\\ 0\\.02342198230353331\ \(0\)\
\-\ characterize\\:\\ 0\\.023104422533498165\ \(0\)\
\-\ sulcal\\:\\ 0\\.022812295863156792\ \(0\)\
\-\ lactate\\:\\ 0\\.021833230218650666\ \(0\)\
\-\ was\\:\\ 0\\.02164111362511723\ \(0\)\
\-\ posterior\\:\\ 0\\.02156538556973484\ \(0\)\
\-\ intraaxial\\:\\ 0\\.02073001535780054\ \(0\)\
\-\ white\\:\\ 0\\.02068689206359137\ \(0\)\
\-\ indistinct\\:\\ 0\\.020425702916417144\ \(0\)\
\-\ falx\\:\\ 0\\.019884024065620523\ \(0\)\
\-\ mr\\:\\ 0\\.01981897424778419\ \(0\)\
\-\ 2\\.4\\:\\ 0\\.019412448403284734\ \(0\)\
\-\ extraaxial\\:\\ 0\\.019197702052836073\ \(0\)\
\-\ lesion\\:\\ 0\\.019057174007304247\ \(0\)\
\-\ multiforme\\:\\ 0\\.018121791322103793\ \(0\)\
\-\ evaluation\\:\\ 0\\.018118531356400056\ \(0\)\
\-\ sulci\\:\\ 0\\.017823696318402086\ \(0\)\
\-\ edema\\:\\ 0\\.01764177729511891\ \(0\)\
\-\ mg\\/dl\\:\\ 0\\.017548121309248273\ \(0\)\
\-\ glioblastoma\\:\\ 0\\.017170235619683165\ \(0\)\
\-\ horn\\:\\ 0\\.016938434868871755\ \(0\)\
\-\ lobe\\:\\ 0\\.01678339670017178\ \(0\)\
\-\ whether\\:\\ 0\\.016773761747410187\ \(0\)\
\-\ significant\\:\\ 0\\.01677260694200163\ \(0\)\
\-\ protein\\:\\ 0\\.01600256067563206\ \(0\)\
\-\ 75\\:\\ 0\\.015959369224365624\ \(0\)\
\-\ concern\\:\\ 0\\.015515219826637453\ \(0\)\
\-\ characteristics\\:\\ 0\\.015515219826637453\ \(0\)\
\-\ disease\\:\\ 0\\.015292746801631799\ \(0\)\
\-\ c\\:\\ 0\\.01482455559438005\ \(0\)\
\-\ reactive\\:\\ 0\\.014762167151462894\ \(0\)\
\-\ slight\\:\\ 0\\.014670539702079405\ \(0\)\
\-\ demonstrate\\:\\ 0\\.014353665265204676\ \(0\)\
\-\ mri\\:\\ 0\\.014330480692807443\ \(0\)\
\-\ deficits\\:\\ 0\\.014270962209956455\ \(0\)\
\-\ margins\\:\\ 0\\.014164395951955497\ \(0\)\
\-\ present\\:\\ 0\\.01408765513818745\ \(0\)\
\-\ it\\:\\ 0\\.014020791127978223\ \(0\)\
\-\ important\\:\\ 0\\.014010163071335487\ \(0\)\
\-\ necessary\\:\\ 0\\.013814162418153513\ \(0\)\
\-\ extends\\:\\ 0\\.01351653516645969\ \(0\)\
\-\ pending\\:\\ 0\\.0134946153706195\ \(0\)\
\-\ neurological\\:\\ 0\\.0134946153706195\ \(0\)\
\-\ suspected\\:\\ 0\\.013429634988745387\ \(0\)\
\-\ suggest\\:\\ 0\\.013282367486834559\ \(0\)\
\-\ right\\:\\ 0\\.013162506702341849\ \(0\)\
\-\ sequences\\:\\ 0\\.013023702013890555\ \(0\)\
\-\ single\\:\\ 0\\.012641095950695005\ \(0\)\
\-\ narrowing\\:\\ 0\\.012505279905656924\ \(0\)\
\-\ extensive\\:\\ 0\\.012472101176820238\ \(0\)\
\-\ irregular\\:\\ 0\\.012439221359512333\ \(0\)\
\-\ in\\:\\ 0\\.012303568763219122\ \(0\)\
\-\ base\\:\\ 0\\.012217001032231266\ \(0\)\
\-\ meningioma\\:\\ 0\\.011993026775383485\ \(0\)\
\-\ images\\:\\ 0\\.01196542986824346\ \(0\)\
\-\ has\\:\\ 0\\.011713138470761152\ \(0\)\
\-\ ventricle\\:\\ 0\\.011687555903570904\ \(0\)\
\-\ which\\:\\ 0\\.01164339114775583\ \(0\)\
\-\ weakness\\:\\ 0\\.01158252318623498\ \(0\)\
\-\ extremity\\:\\ 0\\.011405689670227875\ \(0\)\
\-\ n\\/a\\:\\ 0\\.011296374625398125\ \(0\)\
\-\ effect\\:\\ 0\\.011042183405362208\ \(0\)\
\-\ new\\:\\ 0\\.0108678393313889\ \(0\)\
\-\ recent\\:\\ 0\\.010484376090656193\ \(0\)\
\-\ by\\:\\ 0\\.010385919001787407\ \(0\)\
\-\ initial\\:\\ 0\\.01033424139882959\ \(0\)\
\-\ back\\:\\ 0\\.010288563267691522\ \(0\)\
\-\ study\\:\\ 0\\.01026142830970788\ \(0\)\
\-\ surrounding\\:\\ 0\\.01025242797213418\ \(0\)\
\-\ several\\:\\ 0\\.010025886261760538\ \(0\)\
\-\ medial\\:\\ 0\\.009975545670036686\ \(0\)\
\-\ differential\\:\\ 0\\.009901313245813611\ \(0\)\
\-\ known\\:\\ 0\\.009868799578335108\ \(0\)\
\-\ adjacent\\:\\ 0\\.009860716219468128\ \(0\)\
\-\ onset\\:\\ 0\\.009844603014325364\ \(0\)\
\-\ frontal\\:\\ 0\\.009796685892275026\ \(0\)\
\-\ enhancing\\:\\ 0\\.009780852309798391\ \(0\)\
\-\ brain\\:\\ 0\\.009384494610594022\ \(0\)\
\-\ infection\\:\\ 0\\.009065753919973748\ \(0\)\
\-\ lung\\:\\ 0\\.009033427446126811\ \(0\)\
\-\ lymphoma\\:\\ 0\\.008913133702151407\ \(0\)\
\-\ axial\\:\\ 0\\.008900698817765954\ \(0\)\
\-\ secondary\\:\\ 0\\.008719087469010246\ \(0\)\
\-\ he\\:\\ 0\\.008701413657054815\ \(0\)\
\-\ performed\\:\\ 0\\.00869554135484423\ \(0\)\
\-\ cm\\:\\ 0\\.008364803349697029\ \(0\)\
\-\ lesions\\:\\ 0\\.008348760972058203\ \(0\)\
\-\ is\\:\\ 0\\.008208624501966797\ \(0\)\
\-\ both\\:\\ 0\\.007964233542650077\ \(0\)\
\-\ metastatic\\:\\ 0\\.007850764246774052\ \(0\)\
\-\ surgery\\:\\ 0\\.007572989285986404\ \(0\)\
\-\ into\\:\\ 0\\.007420899153137616\ \(0\)\
\-\ man\\:\\ 0\\.007375663660912406\ \(0\)\
\-\ a\\:\\ 0\\.00723722266092338\ \(0\)\
\-\ diagnosis\\:\\ 0\\.007161384418906642\ \(0\)\
\-\ lower\\:\\ 0\\.007014095143663732\ \(0\)\
\-\ contrast\\:\\ 0\\.006980933163532501\ \(0\)\
\-\ demonstrates\\:\\ 0\\.006812486137420387\ \(0\)\
\-\ lateral\\:\\ 0\\.0067396644000896\ \(0\)\
\-\ \\-\\:\\ 0\\.006685140360249502\ \(0\)\
\-\ but\\:\\ 0\\.006651471901582254\ \(0\)\
\-\ no\\:\\ 0\\.006280614238713883\ \(0\)\
\-\ patient\\:\\ 0\\.006252495846105021\ \(0\)\
\-\ to\\:\\ 0\\.006234570926174981\ \(0\)\
\-\ the\\:\\ 0\\.00605471319869894\ \(0\)\
\-\ that\\:\\ 0\\.005386790980141691\ \(0\)\
\-\ on\\:\\ 0\\.005283876002667358\ \(0\)\
\-\ \\(\\:\\ 0\\.005272713330247157\ \(0\)\
\-\ \\)\\:\\ 0\\.005208304321994928\ \(0\)\
\-\ ct\\:\\ 0\\.004362422092671689\ \(0\)\
\-\ mass\\:\\ 0\\.004337448930465564\ \(0\)\
\-\ an\\:\\ 0\\.004312645490090254\ \(0\)\
\-\ \\:\\:\\ 0\\.004125090569308996\ \(0\)\
\-\ or\\:\\ 0\\.003655192514466086\ \(0\)\
\-\ this\\:\\ 0\\.0035078000485917263\ \(0\)\
\-\ year\\:\\ 0\\.003489435289317207\ \(0\)\
\-\ left\\:\\ 0\\.003489435289317207\ \(0\)\
\-\ of\\:\\ 0\\.00340157082621864\ \(0\)\
\-\ and\\:\\ 0\\.003284835871025884\ \(0\)\
\-\ old\\:\\ 0\\.003193191959351294\ \(0\)\
\-\ for\\:\\ 0\\.002660978644681442\ \(0\)\
\-\ with\\:\\ 0\\.0021351127023702503\ \(0\)\
\-\ \\.\\:\\ 0\\.0018138449100833863\ \(0\)\
\-\ \\,\\:\\ 0\\.0009879929398441145\ \(0\)\
